Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

China Arrests 135 for Illegally Buying, Selling Vaccines

By AP | May 23, 2016

BEIJING (AP) — China has arrested 135 people in 22 provinces for illegally buying and selling vaccines, in the latest scandal shaking the Chinese public’s confidence in vaccine safety.

In an online statement Friday, the national prosecuting office said arrest warrants were issued for 125 people for running vaccine businesses without license.

It said 15 of them have been formally indicted, and two were found guilty. Ten health officials were arrested for on-duty negligence.

The accused health officials had worked at local public health centers and knowingly bought the illegal vaccines and used them on people, the prosecuting office said.

The massive investigation followed a case in March when a doctor in the eastern province of Shandong were found to have sold 2 million doses of improperly stored or expired vaccines. Media reports said she stored the vaccines at room temperature, instead of keeping them refrigerated as required.

Vaccines not stored and managed properly can lose their effectiveness and may not protect people being inoculated. The vaccines in the March case included those for hepatitis B, rabies, mumps and Japanese encephalitis.

The scandal drew criticism from people upset with persistent food and drug safety issues in the country. Beijing quickly ordered an investigation to crack down on illegal businesses of vaccines.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE